Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder
ICD-10 F13.94 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder.
F13.94 refers to a condition characterized by the use of sedative, hypnotic, or anxiolytic substances that leads to a mood disorder. This code is used when the specific substance is not identified, but the patient exhibits symptoms of mood disturbance as a result of their substance use. Sedatives, hypnotics, and anxiolytics are commonly prescribed for anxiety, insomnia, and other related conditions. However, misuse or prolonged use can lead to dependence, withdrawal symptoms, and mood disorders such as depression or anxiety. Clinicians must assess the patient's substance use history, current symptoms, and any co-occurring mental health disorders to provide appropriate treatment. Treatment may involve detoxification, counseling, and medication management to address both the substance use disorder and the mood disorder. Accurate coding is essential for proper treatment planning and reimbursement.
Detailed patient history, including substance use and mood symptoms.
Patients presenting with anxiety or depression linked to substance use.
Consideration of co-occurring disorders and comprehensive treatment plans.
Thorough assessment of substance use patterns and withdrawal symptoms.
Patients undergoing detoxification with mood disturbances.
Focus on integrated treatment approaches for substance use and mood disorders.
Used when assessing a patient for substance use and mood disorders.
Comprehensive assessment notes and treatment plan.
Psychiatric evaluations should include substance use history.
F13.94 is significant as it captures the relationship between sedative, hypnotic, or anxiolytic use and mood disorders, allowing for targeted treatment and better understanding of patient needs.
